Guggenheim Capital LLC Insulet Corp Transaction History
Guggenheim Capital LLC
- $14 Billion
- Q1 2024
A detailed history of Guggenheim Capital LLC transactions in Insulet Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 15,125 shares of PODD stock, worth $2.98 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,125
Previous 6,932
118.19%
Holding current value
$2.98 Million
Previous $1.5 Million
72.34%
% of portfolio
0.02%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding PODD
# of Institutions
613Shares Held
62.9MCall Options Held
339KPut Options Held
916K-
Vanguard Group Inc Valley Forge, PA8.2MShares$1.61 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.56MShares$1.49 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$1.19 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.92MShares$574 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA1.99MShares$392 Million0.06% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $13.7B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...